Akcea Therapeutics, Inc. Made Big Gain

Mon 31 Aug 20 at 05:30 PM

Akcea Therapeutics, Inc. (AKCA:NASDAQ) jumped higher at $18.28, representing a gain of 60.6%. The stock got featured on our News Catalysts scanner on Mon 31 Aug 20 at 02:13 PM in the 'INVESTOR UPDATE' category. From Fri 14 Aug 20, the stock recorded 60.00% Up Days and 63.64% Green Days

The share price of the company has been moving sideways in recent weeks.

About Akcea Therapeutics, Inc. (AKCA:NASDAQ)

Akcea Therapeutics Inc is a late stage biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders.

Top 10 Gainers:

Aimmune Therapeutics, Inc. (AIMT:NASDAQ), 171.59%
MCAC (MCAC:NASDAQ), 100%
Akcea Therapeutics, Inc. (AKCA:NASDAQ), 60.63%
Hermitage Offshore Services Ltd. (PSV:NYSE), 50.59%
Genworth Financial, Inc. (GNW:NYSE), 27.43%
I-Mab (IMAB:NASDAQ), 27.23%
GameStop Corp. (GME:NYSE), 23.93%
AgEagle Aerial Systems, Inc. (UAVS:NYSEMKT), 23.02%
Huitao Technology Co., Ltd. (HHT:NASDAQ), 22.94%
ChinaNet Online Holdings, Inc. (CNET:NASDAQ), 22.22%